GlassScriptPhysician profile
Bradley Barnett
NPI 1154765139
$11,749.79
in general payments reported to CMS, 2019-2025
29 companies · $2,201 in 2025
The $2,201 reported for 2025 was more than what 85% of Cornea and External Diseases Specialist providers received nationally (typical 2025 total: $477).
See the full distribution for Cornea and External Diseases Specialist
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $249 · 2020: $724 · 2021: $1,542 · 2022: $1,935 · 2023: $2,520 · 2024: $2,579 · 2025: $2,201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,673 · Consulting Fee: $2,535 · Entertainment: $47.87 · Honoraria: $25.59 · Education: $17.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,672.97 |
| Consulting Fee | $2,535.00 |
| Entertainment | $47.87 |
| Honoraria | $25.59 |
| Education | $17.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,614.58 | 2022-2024 | Durysta |
| Mallinckrodt Hospital Products INC. | $1,485.01 | 2023-2025 | Acthar |
| Alcon Vision LLC | $1,065.09 | 2020-2025 | Tryptyr, Wavelight Refractive Suite, Wavelight Ex500 Excimer Laser |
| Sight Sciences, INC. | $1,002.75 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument, Tearcare System |
| Allergan, INC. | $631.86 | 2020-2022 | |
| Johnson & Johnson Vision Care, INC. | $608.38 | 2021-2023 | Acuvue |
| Sun Pharmaceutical Industries INC. | $600.06 | 2020-2025 | Cequa |
| Rayner Intraocular Lenses Limited | $577.46 | 2022-2025 | Omidria, Rayner Cataract Set 1, Rayone Aspheric |
| Rxsight INC | $506.67 | 2021-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Novartis Pharmaceuticals Corporation | $421.28 | 2021-2023 | |
| Harrow Eye, LLC | $292.70 | 2024-2025 | Vevye, Natacyn, Tobradex St |
| Johnson & Johnson Surgical Vision, INC. | $264.08 | 2021-2025 | Tecnis Iol |
| Bausch & Lomb Americas INC. | $196.07 | 2023-2025 | Miebo, Scoutpro Osmolarity System, Envista Mx60 Iol |
| Biotissue Holdings INC. | $183.69 | 2020-2025 | |
| Glaukos Corporation | $178.49 | 2020-2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $158.99 | 2019-2021 | |
| Dompe US, INC. | $149.07 | 2021-2025 | Oxervate |
| Horizon Therapeutics Plc | $131.93 | 2023 | Tepezza |
| Shire North American Group INC | $123.88 | 2019 | |
| Beaver-Visitec International, INC. | $113.97 | 2021-2024 | |
| Aerie Pharmaceuticals, INC. | $108.23 | 2021 | |
| Tarsus Pharmaceuticals, INC. | $70.59 | 2024 | Xdemvy |
| Amgen INC. | $58.04 | 2024 | Tepezza |
| Merz North America, INC. | $53.38 | 2024-2025 | |
| Optos, INC. | $47.87 | 2023 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Carl Zeiss Meditec USA, INC. | $38.69 | 2022 | |
| Ivantis, INC | $23.61 | 2021 | |
| Oyster Point Pharma, INC. | $22.49 | 2022 | |
| Edwards Lifesciences Corporation | $20.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bradley Barnett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.